144,26 €
160,29 €
-10% with code: EXTRA
Law and the Regulation of Medicines
Law and the Regulation of Medicines
144,26
160,29 €
  • We will send in 10–14 business days.
The principal purpose of this book is to tell the story of a medicine's journey through the regulatory system in the UK, from the definition of a medicine, through clinical trials, licensing, pharmacovigilance, litigation, marketing, and funding. While the UK's regulatory regime is the principal focus, the question of global access to medicines is addressed, not only because of its political importance, but also because it is an issue which places the question of whether medicines are a private…
160.29
  • SAVE -10% with code: EXTRA

Law and the Regulation of Medicines (e-book) (used book) | bookbook.eu

Reviews

Description

The principal purpose of this book is to tell the story of a medicine's journey through the regulatory system in the UK, from the definition of a medicine, through clinical trials, licensing, pharmacovigilance, litigation, marketing, and funding. While the UK's regulatory regime is the principal focus, the question of global access to medicines is addressed, not only because of its political importance, but also because it is an issue which places the question of whether medicines are a private or a public good in particularly stark focus. Two specific challenges to the future of medicines regulation are examined separately: pharmacogenetics, or the genetic targeting of medicines to subgroups of patients, and the possibility of using medicines to enhance wellbeing or performance, rather than treat disease. Throughout, the emphasis is upon the role of regulation in shaping and influencing the operation of the medicines industry, an issue which is of central importance to the promotion of public health and the fair and equitable distribution of healthcare resources. The book will be of interest to medical lawyers and scholars interested in medical law, as well as those who deal with the regulation of medicines on a professional basis.

EXTRA 10 % discount with code: EXTRA

144,26
160,29 €
We will send in 10–14 business days.

The promotion ends in 21d.21:55:44

The discount code is valid when purchasing from 10 €. Discounts do not stack.

Log in and for this item
you will receive 1,60 Book Euros!?
  • Author: Emily Jackson
  • Publisher:
  • Year: 2012
  • Pages: 308
  • ISBN-10: 1849461791
  • ISBN-13: 9781849461795
  • Format: 15.8 x 23.1 x 1.5 cm, minkšti viršeliai
  • Language: English English

The principal purpose of this book is to tell the story of a medicine's journey through the regulatory system in the UK, from the definition of a medicine, through clinical trials, licensing, pharmacovigilance, litigation, marketing, and funding. While the UK's regulatory regime is the principal focus, the question of global access to medicines is addressed, not only because of its political importance, but also because it is an issue which places the question of whether medicines are a private or a public good in particularly stark focus. Two specific challenges to the future of medicines regulation are examined separately: pharmacogenetics, or the genetic targeting of medicines to subgroups of patients, and the possibility of using medicines to enhance wellbeing or performance, rather than treat disease. Throughout, the emphasis is upon the role of regulation in shaping and influencing the operation of the medicines industry, an issue which is of central importance to the promotion of public health and the fair and equitable distribution of healthcare resources. The book will be of interest to medical lawyers and scholars interested in medical law, as well as those who deal with the regulation of medicines on a professional basis.

Reviews

  • No reviews
0 customers have rated this item.
5
0%
4
0%
3
0%
2
0%
1
0%
(will not be displayed)